Author:
Kubo Sousuke,Kobayashi Nobuaki,Matsumoto Hiromi,Somekawa Kohei,Kaneko Ayami,Hashimoto Hisashi,Teranishi Shuhei,Watanabe Keisuke,Horita Nobuyuki,Hara Yu,Kudo Makoto,Kaneko Takeshi
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference25 articles.
1. Belluomini L, Calvetti L, Inno A, Pasello G, Roca E, Vattemi E et al (2022) SCLC treatment in the immuno-oncology era: current evidence and unmet needs. Front Oncol 14:12
2. Byers LA, Rudin CM (2015) Small cell lung cancer: Where do we go from here? Cancer 121(5):664–672
3. Chute JP, Chen T, Feigal E, Simon R, Johnson BE (1999) Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress. J Clin Oncol 17(6):1794–1794
4. Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ (2020) Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med 18(1):360
5. Ding H, Xin W, Tong Y, Sun J, Xu G, Ye Z et al (2020) Cost effectiveness of immune checkpoint inhibitors for treatment of non-small cell lung cancer: A systematic review. PLoS ONE 15(9):e0238536